Economic Impact

​

Implementing whole genome sequencing (WGS) for infection prevention control can lead to substantial cost savings. According to our published peer reviewed economic impact study, proactive WGS interventions can save hospitals significant amounts annually. 

​

• Cost Savings: In an 800-bed hospital, proactive WGS can reduce healthcare-associated infections (HAIs) by over 400 per year, resulting in savings of over £2 million annually. 

• Return on Investment: For every £1 spent on proactive WGS interventions, hospitals can expect a return of £7, demonstrating a highly efficient use of resources. 

​

Health Impact 

​

By leveraging the IDEM platform for WGS, hospitals can significantly improve patient outcomes and reduce the burden of HAIs.

 

• Infection Reduction: Proactive WGS enables the early detection of transmission chains, source insights and early intervention strategies to reduce the number of HAIs.

• Enhanced Accuracy: IDEM's near-zero error SNP error rate provides the deepest accuracy to distinguish genuine outbreaks from clusters of similar bacteria, ensuring precise source attribution and intervention deployment. 

​

Peer-Reviewed Evidence 

 

Our findings are backed by rigorous research and real-world applications:

 

• Published data: A study titled "Economic Impact of a WGS Intervention for HAIs in England and the USA" highlights the financial and clinical benefits of implementing WGS in healthcare settings. 

• Real-World Applications: These materials illustrate the practical benefits of IDEM in real-world settings, showcasing how the platform can enable proactive WGS through scale and accuracy that was previously not possible. By reducing infections and the need for antibiotics, IDEM can play an important role in combating antimicrobial resistance (AMR). 

 

Learn More About IDEM 

 

The IDEM platform offers: 

​

• High-Resolution: Reference-free analysis enables the comprehensive comparison of larger areas of genomic data, providing a high-resolution assessment of bacterial relatedness.

• High Accuracy: Achieve near-zero SNP errors, ensuring outbreaks are identified correctly.

• User-Friendly: With dashboards designed for clinical and IPC teams, IDEM makes complex genomic data accessible and actionable. 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

​

Apply for a Grant 

 

To support the community in establishing this technology we are offering project grants for the analysis of 100 samples to selected groups. We will review the applications along with esteemed professionals including Professors Jon Cohen and David Livermore. Only five grants will be awarded, with the first selections occurring by 15th August 2024, and the final application deadline 5th September 2024. 

​​

Click here to apply now 

​

 

Contact Us 

​

If you have any questions or would like to see a demonstration of the IDEM platform, please get in touch with us. 

​

Click here to contact us 

​

 

Further Information:

​​

​

​​

​​